TABLE 2.
Genetic marker | Body weight | Lean mass | EE | Fat mass | Food intake | GTT | ITT | References |
---|---|---|---|---|---|---|---|---|
Glp‐1r −/− | Scrocchi et al., 1996; Scrocchi & Drucker, 1998; Hansotia et al., 2007; Ayala et al., 2010 | |||||||
Chow (Purina 5001; Research Diets 10% kcal from fat) | ||||||||
Male | ↔ Up to 16 months | N/A | N/A | N/A | ↔ and ↑ ( Hansotia et al., 2007 ) | Impairment that subsides with age | N/A | |
Female | ↔ Up to 6 months; Δ at 11/16 months | N/A | N/A | N/A | ↔ | Impairment that persists with age | N/A | |
HFD (Research Diets D12451; BioServ F3282) | ||||||||
Male | Protected from weight gain (D12451 @ 9–12 weeks age); ↔ F3282 @ 3 weeks age) | ↓ | N/A | ↔ | ↔ and ↑ ( Hansotia et al., 2007 ) | Impaired | N/A | |
Female | Protected from weight gain (F3282 @ 3 weeks age and D12451 @ 12 weeks age) | ↓ | N/A | ↓ | N/A | Impaired | N/A | |
Nestin‐Cre (JAX #3771); GLP‐1 receptor lox/lox | Sisley et al., 2014 | |||||||
Chow (Harlan Teklad no. 7012) | ↔ | ↔ | N/A | ↔ | ↔ (4 hr & 24 hr); however, separate cohorts saw ↑ | Trend toward impairment | N/A | |
High Fat Diet (D12331) | ↔ | ↔ | N/A | ↔ | ↔ (4 hr, 24 hr, & 7 days) | ↔ | N/A | |
Vgat‐iCre, GLP‐1 receptor lox/lox | Adams et al., 2018 | |||||||
Standard chow | ||||||||
Male | ↔ | N/A | N/A | N/A | ↔ | N/A | N/A | |
Female | ↔ | N/A | N/A | N/A | ↔ | N/A | N/A | |
HFD (D12451); male only | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
Vglut‐iCre, GLP‐1 receptor lox/lox | Adams et al., 2018 | |||||||
Standard chow | ||||||||
Male | ↔ | N/A | N/A | N/A | ↔ | N/A | N/A | |
Female | ↔ | N/A | N/A | N/A | ↔ | N/A | N/A | |
HFD (D12451); male only | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
Phox2b‐Cre (JAX #016223); GLP‐1 receptor lox/lox | Sisley et al., 2014 | |||||||
Chow (Harlan Teklad no. 7012) | ↔ | ↔ | N/A | ↔ | ↔ (4 hr & 24 hr) | Trend toward impairment | N/A | |
HFD (D12331) | ↔ | ↔ | N/A | ↔ | ↔ (4 hr, 24 hr, & 7 days) | Trend toward impairment | ||
Nkx2.1‐Cre (JAX #8661); GLP‐1 receptor lox/lox | Burmeister et al., 2017 | |||||||
Chow (Harlan Teklad #2016) | ↔ | ↔ | ↑ (48 hr) | ↔ | ↑ | ↔ | N/A | |
HFD (D12492) | ↓ | ↔ | ↑ (48 hr) | ↓ | ↔ | Trend toward impairment | N/A | |
POMC‐Cre (JAX #5965); GLP‐1 receptor lox/lox | Burmeister et al., 2017 | |||||||
Chow (Harlan Teklad #2016) | ↔ | ↔ | ↔ (48 hr) | ↔ | ↔ | ↔ | N/A | |
HFD (D12492) | ↑ | ↔ | ↔ (48 hr) | ↔ | ↔ | ↔ | N/A | |
Sim1‐Cre (JAX #6395); GLP‐1 receptor lox/lox | Burmeister et al., 2017 Ghosal et al., 2017 | |||||||
Chow (Harlan Teklad #2016) | ↔ | ↔ | ↓ (48 hr) | ↔ | ↔ | Trend toward improvement | N/A | |
HFD (D12492) | Δ | ↔ | ↔ (48 hr) | ↔ | ↔ | Trend toward improvement | ||
PVH ‐ AAV‐Cre; GLP‐1 receptor lox/lox | Liu et al., 2017 | |||||||
Standard chow | ↑ | N/A | ↔ | N/A | ↑ | N/A | Impaired | |
HFD | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
PVH lesion | Secher et al., 2014 | |||||||
Chow (no. 1324, Altromin, Brogaarden) | ↑ | N/A | N/A | N/A | N/A | N/A | N/A | |
HFD | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
PpgGLP1‐NTSKO | Cheng et al., 2020 | |||||||
Chow (Purina Lab Diet, 5001) | ↔ | ↔ | N/A | ↔ | ↔ | N/A | N/A | |
HCD (Research Diets D12492) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
PpgLepRbKO | ||||||||
Chow (Purina Lab Diet, 5001) | ↔ | ↔ | N/A | ↔ | ↔ | N/A | N/A | |
HCD (Research Diets D12492) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: ↑/↓ statistically significant response; Δ/∇ non‐significant trend; ↔ equivalent to control/ wild type.
Abbreviations: DIO, diet‐induced obese mice; EE, energy expenditure; HFD/HCD, high fat/high caloric diet; NTS, nucleus tractus solitarius; PVN, paraventricular hypothalamic nucleus.